$9.820
-0.981 (-9.99%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CLYM Prediction & Forecast by Similar Chart Analysis
Alphio's CLYM stock price prediction model matches the current Climb Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.82 (-0.02%). The 1-week path is $9.78 (-0.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Climb Bio Inc Stock?
Climb Bio Inc is currently a hold. The stock has a current price of $9.82, with a significant year-to-date change of +161.87%, but it has recently dropped by 10.73% over the past five days. The RSI is at 27.546, indicating that the stock is oversold, which could suggest a potential rebound. However, the company continues to report negative earnings, with a forward P/E ratio of 0 and a net income loss of $13.72 million in Q1 2026. The main risk is the ongoing financial losses, which could impact investor confidence.
CLYM stock price ended at $9.82 on Friday, after losing -9.99%
Climb Bio Inc (CLYM) last closed at $9.82, losing -9.99%. These facts feed the 1-day and 1-week CLYM price prediction above.
Forecast Drivers
Climb Bio Inc (CLYM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CLYM, ranked by similarity.
Seasonality analysis for CLYM
Historically the probability of a positive October return for CLYM is 68.97%. September offers the highest probability of a positive month at 93.55%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CLYM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $1.43 | $1.80 | $2.11 | -81.65% |
| Nov 2026 | $1.57 | $1.82 | $2.13 | -81.44% |
| Dec 2026 | $1.09 | $1.46 | $1.46 | -85.16% |
In 2026, Climb Bio Inc (CLYM) is projected to range from $1.09 to $2.13.
Climb Bio Inc 2026 monthly forecast
In Oct 2026, Climb Bio Inc is projected to average $1.80, with a low of $1.43 and high of $2.11.
In Nov 2026, Climb Bio Inc is projected to average $1.82, with a low of $1.57 and high of $2.13.
In Dec 2026, Climb Bio Inc is projected to average $1.46, with a low of $1.09 and high of $1.46.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.